Neonatal Fc Receptor Blocker
- Name
- Neonatal Fc Receptor Blocker
- Accession Number
- DBCAT005831
- Description
Not Available
- Drugs
Drug Drug Description Efgartigimod alfa A neonatal Fc receptor blocker used to treat generalized myasthenia gravis in patients who are AChR-antibody positive. Rozanolixizumab A humanized monoclonal antibody targeting the human neonatal Fc receptor (FcRn) used to treat generalized myasthenia gravis. - Drugs & Drug Targets
Drug Target Type Efgartigimod alfa IgG receptor FcRn large subunit p51 target Rozanolixizumab IgG receptor FcRn large subunit p51 target